Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alabama for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alabama only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alabama (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Matthew Tucker (NPI 1891158176)

Field	Value
Entity Type	Individual
Organization	Matthew Tucker
Address	3670 Grandview Pkwy
City	Birmingham
State	AL
ZIP	35243
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 3, 2016

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

Practice and service line: The provider’s Medicare billing profile is dominated by high-volume infusion and injectable therapeutics consistent with a hematology/oncology specialty — the top codes are J1556 (immune globulin), J1568 (immune globulin), and J1439 (ferric carboxymaltose), indicating large-scale outpatient IV medication administration and supportive care services rather than primarily office-based evaluation-and-management encounters. Multiple chemotherapy and infusion administration codes (96413, 96365, 96366, 96417) also appear in the top codes, reinforcing an infusion-centric practice model focused on biologic and chemotherapeutic treatments.

Revenue concentration: Medicare revenue is heavily concentrated in a small set of drug administration codes: the precomputed top three Medicare codes account for 79.5% of this provider’s total Medicare revenue, with J1556 alone representing $711.2K and 55.5% of Medicare revenue. This concentration suggests the business’s financial performance is reliant on a few high-revenue injectable products and associated administration claims.

Payer mix: This provider is effectively single-payer in the public programs captured here — lifetime Medicare revenue totals $1.3M while there is no Medicaid billing on file. Analysts should treat this entity as Medicare-centric, with no Medicaid footprint to compare for state-level behavioral differences or cross-payer leverage.

Competitive standing on leading codes: For the largest revenue code J1556 the provider ranks #11 of 46 nationally (78th percentile), which places them as a relatively active national participant for that specific immune globulin product but not an outlier or market leader. For J1568 they rank #53 of 381 (86th percentile), indicating above-typical national activity for that formulation as well; several other top drug codes (e.g., J1439) show high national percentiles (J1439 at 94th) reflecting comparatively strong volume in specific IV iron and infusion therapies.

Statistical outliers and notable volume signals: Several service codes are flagged as “notably above typical national volume” such as 99213 and J1100, indicating the provider reports substantially higher-than-typical volumes for routine office E/M visits and certain supportive injections relative to peers. Most infusion and chemotherapy administration codes are described as “typical, unremarkable volume,” which suggests the practice operates at expected scale for oncology infusion services except for a few elevated areas.

Operational implications for payers: The large share of drug revenue tied to J1556 and J1568 implies that utilization management, drug sourcing, and reimbursement terms for IVIG products will disproportionately affect this provider’s Medicare revenue. Given the lack of Medicaid claims, payer negotiations or network design changes in Medicaid will have no immediate direct impact on this provider’s publicly reported revenue.

Tenure and stability: The provider’s NPI was enumerated on 2016-04-03 (approximately 10 years ago), indicating roughly a decade of activity in Medicare billing records; this tenure supports treating observed patterns as established practice behavior rather than a short-term anomaly.

Procedure mix nuance: While high-revenue injectable products dominate, the presence of substantial counts for basic lab and ancillary services (36415 blood draws, 85025 CBC) and a range of infusion add-on codes (96367, 96417, 96415) indicates the practice delivers end-to-end infusion episodes including monitoring and multi-drug administrations rather than single-dose procedures. This breadth suggests resource needs consistent with an infusion center model (nursing, pharmacy handling, and procedure room capacity).

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1556	Injection, immune globulin (bivigam), 500 mg	12,700	$60	$711.2K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	7,000	$30	$217K
J1439	Injection, ferric carboxymaltose, 1 mg	91,500	$1	$91.5K
J0897	Injection, denosumab, 1 mg	4,680	$20	$84.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	710	$60	$43.4K
J1437	Injection, ferric derisomaltose, 10 mg	1,600	$20	$25.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	240	$90	$21.1K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	450	$40	$18.9K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	1,410	$10	$11.3K
99223	The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…	80	$130	$10.7K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alabama Distribution

Matthew Tucker — 3 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alabama

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J1556	1	10	5,820	$60	$339.8K
J1568	11	30	5,180	$30	$316.2K
J0897	72	200	3,120	$20	$97.7K
J1437	33	40	3,000	$20	$59.1K
J1439	2	10	41,250	$1	$39K
96413	55	150	150	$90	$20.2K
99214	3,733	7,330	120	$80	$16.8K
99232	1,982	2,530	100	$60	$13.3K
99223	451	2,140	40	$130	$8.1K
99213	146	6,470	80	$50	$7.9K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Matthew Tucker, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Benjamin Jones	AL	Hematology & Oncology Physician	$2.4M	$0
Birmingham Hematology Oncology Assoc LLC	AL	Hematology & Oncology Physician	$0	$1.1M
Cara Bondly	AL	Hematology & Oncology Physician	$986.3K	$0
Joanne Rossman	AL	Hematology & Oncology Physician	$874.6K	$0
John Piede	AL	Hematology & Oncology Physician	$774.1K	$0
Christopher Wang	AL	Hematology & Oncology Physician	$760.3K	$0
Carter Capra	AL	Hematology & Oncology Physician	$741.9K	$0
Racquel Innis-shelton	AL	Hematology & Oncology Physician	$422.5K	$0
Daniel Allendorf	AL	Student in an Organized Health Care Education/Training Program	$375.7K	$0
Ashley Fry	AL	Hematology & Oncology Physician	$358.2K	$0

Nearby Providers

Other providers in the same ZIP code as Matthew Tucker, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Taustin Laboratories	AL	Clinical Medical Laboratory	$54.1K	$37M
The Children's Hospital Of Alabama	AL	Pediatric Otolaryngology Physician	$0	$15.8M
Wiregrass Hospice, LLC	AL	Community Based Hospice Care Agency	$0	$3.5M
Compassus Op Of Alabama LLC	AL	Community Based Hospice Care Agency	$0	$3.5M
Vuepoint Diagnostics, LLC	AL	Portable X-ray and/or Other Portable Diagnostic Imaging Supplier	$1.3M	$181.3K
Continuumrx, Inc.	AL	Home Infusion Therapy Pharmacy	$0	$1.3M
Agape Care Alabama LLC	AL	Community Based Hospice Care Agency	$0	$1.1M
Affinity Hospital LLC	AL	General Acute Care Hospital	$0	$904.8K
Journey Hospice Of Alabama,llc	AL	Community Based Hospice Care Agency	$0	$896.8K
Puzzle Piece LLC	AL	Pediatric Occupational Therapist	$0	$867.1K

Matthew Tucker — Billing Profile & Reimbursement Data

Sign up for Matthew Tucker — Billing Profile & Reimbursement Data policy alerts

Matthew Tucker — Billing Profile & Reimbursement Data

Sign up for Matthew Tucker — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References